Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Biliary Tract Neoplasms × atezolizumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 57 Carcinoma, Hepatocellular 45 Lung Neoplasms 27 Breast Neoplasms 26 Small Cell Lung Carcinoma 17 Neoplasms 17 Triple Negative Breast Neoplasms 16 Neoplasm Metastasis 16 Carcinoma, Transitional Cell 13 Melanoma 12 Colorectal Neoplasms 12 Urinary Bladder Neoplasms 11 Prostatic Neoplasms 9 Head and Neck Neoplasms 9 Recurrence 8 Ovarian Neoplasms 8 Liver Neoplasms 7 Glioblastoma 7 Mesothelioma, Malignant 6 Endometrial Neoplasms 6 Carcinoma, Renal Cell 6 Sarcoma 5 Rectal Neoplasms 5 Gastrointestinal Neoplasms 5 Carcinoma, Squamous Cell 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Kidney Neoplasms 4

Interventions

Gemcitabine 48 Cisplatin 35 Capecitabine 25 Oxaliplatin 23 durvalumab 16 Fluorouracil 16 Leucovorin 15 Irinotecan 10 lenvatinib 9 pembrolizumab 8 S 1 (combination) 8 Nivolumab 8 Immune Checkpoint Inhibitors 7 130-nm albumin-bound paclitaxel 7 tremelimumab 6 apatinib 6 camrelizumab 5 Trastuzumab 5 Blood Specimen Collection 5 irinotecan sucrosofate 4 Taxes 4 Liquid Biopsy 4 Folfox protocol 4 Drug Therapy 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 tislelizumab 3 surufatinib 3 anlotinib 3 Tegafur 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05052099 2025-09-29

COMBATBIL

University Hospital, Essen

Phase 1/2 Completed

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡